Trials / Completed
CompletedNCT04162912
Motivational Interviewing Tailored Programme for Promoting Advance Care Planning Behaviours
Effects of a Motivational Interviewing Tailored Programme for Promoting Advance Care Planning Behaviours Among Patients With Palliative Care Needs: A Randomised Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 204 (actual)
- Sponsor
- Food and Health Bureau, Hong Kong · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This proposed study is designed to test the effects of motivational interviewing (MI) in increasing the uptake of ACP behaviours among patients with palliative care needs. A randomised controlled trial with repeated blinded outcome assessment will be conducted to assess the effects of a MI-tailored ACP (MI-ACP) programme on palliative care patients recruited from the outpatient palliative care clinics and home palliative care services of two hospitals. A total of 204 patients will be recruited and randomly assigned to experimental and control groups. The patients in the experimental group will receive a MI-ACP programme facilitated by a trained nurse, whereas the patients in the control group will receive usual care. Primary outcome is the behavioural changes in ACP. Secondary outcomes are perceived stress, decisional conflict and quality of life. Study outcomes will be measured at baseline, 1 month and 3 months after enrolment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Motivational Interviewing tailored Advance Care Planning | The trained interventionist who is experienced in MI techniques will explore their illness experiences, emotions and beliefs about their health conditions and future care in an empathetic manner and explore their ambivalence for ACP behaviours. |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2019-11-14
- Last updated
- 2020-04-17
Locations
2 sites across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT04162912. Inclusion in this directory is not an endorsement.